Theratechnologies Stock Current Valuation
| TH Stock | CAD 1.74 0.06 3.57% |
Valuation analysis of Theratechnologies helps investors to measure Theratechnologies' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 27th of November 2024, Enterprise Value Over EBITDA is likely to drop to -8.16. In addition to that, Enterprise Value Multiple is likely to drop to -8.16. Fundamental drivers impacting Theratechnologies' valuation include:
Price Book 19.4616 | Enterprise Value 106.8 M | Enterprise Value Ebitda 6.5475 | Price Sales 0.9489 | Forward PE 17.7936 |
Overvalued
Today
Please note that Theratechnologies' price fluctuation is very risky at this time. Calculation of the real value of Theratechnologies is based on 3 months time horizon. Increasing Theratechnologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Theratechnologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Theratechnologies Stock. However, Theratechnologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.74 | Real 1.47 | Hype 1.74 | Naive 1.78 |
The intrinsic value of Theratechnologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Theratechnologies' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Theratechnologies helps investors to forecast how Theratechnologies stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Theratechnologies more accurately as focusing exclusively on Theratechnologies' fundamentals will not take into account other important factors: Theratechnologies Company Current Valuation Analysis
Theratechnologies' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Theratechnologies Current Valuation | 106.76 M |
Most of Theratechnologies' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theratechnologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Theratechnologies Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Theratechnologies is extremely important. It helps to project a fair market value of Theratechnologies Stock properly, considering its historical fundamentals such as Current Valuation. Since Theratechnologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theratechnologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theratechnologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Theratechnologies has a Current Valuation of 106.76 M. This is 99.26% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all Canada stocks is 99.36% higher than that of the company.
Theratechnologies Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Theratechnologies' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics of similar companies.Theratechnologies is currently under evaluation in current valuation category among its peers.
Theratechnologies Current Valuation Drivers
We derive many important indicators used in calculating different scores of Theratechnologies from analyzing Theratechnologies' financial statements. These drivers represent accounts that assess Theratechnologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theratechnologies' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 709.8M | 1.2B | 831.6M | 41.7M | 37.6M | 35.7M | |
| Enterprise Value | 752.5M | 1.3B | 874.4M | 66.6M | 59.9M | 56.9M |
Theratechnologies Fundamentals
| Return On Equity | -11.17 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 106.76 M | ||||
| Shares Outstanding | 45.98 M | ||||
| Shares Owned By Insiders | 1.22 % | ||||
| Shares Owned By Institutions | 51.56 % | ||||
| Number Of Shares Shorted | 23.02 K | ||||
| Price To Earning | (52.28) X | ||||
| Price To Book | 19.46 X | ||||
| Price To Sales | 0.95 X | ||||
| Revenue | 81.76 M | ||||
| Gross Profit | 56.22 M | ||||
| EBITDA | (9.86 M) | ||||
| Net Income | (23.96 M) | ||||
| Cash And Equivalents | 9.21 M | ||||
| Cash Per Share | 0.35 X | ||||
| Total Debt | 58.97 M | ||||
| Debt To Equity | 6.46 % | ||||
| Current Ratio | 1.90 X | ||||
| Book Value Per Share | (0.43) X | ||||
| Cash Flow From Operations | (5.68 M) | ||||
| Short Ratio | 0.39 X | ||||
| Earnings Per Share | (0.06) X | ||||
| Price To Earnings To Growth | (199.00) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 103 | ||||
| Beta | 1.73 | ||||
| Market Capitalization | 80.01 M | ||||
| Total Asset | 77.77 M | ||||
| Retained Earnings | (408.66 M) | ||||
| Working Capital | 16 M | ||||
| Current Asset | 34.42 M | ||||
| Current Liabilities | 16.85 M | ||||
| Net Asset | 77.77 M |
About Theratechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theratechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Theratechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theratechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theratechnologies will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Theratechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theratechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theratechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theratechnologies to buy it.
The correlation of Theratechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theratechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theratechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Theratechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.